NCT04302233

Brief Summary

Recently joint and breast prostheses were placed under special post-marketing surveillance in order to prevent new occurrence of serious incidents by agency for medicines and health products safety. Few of french patient are able to identify their prosthesis in the event on health security alert. An usual postoperative pharmaceutical support (UPS) for patients with joint prosthesis has been implemented to prepare them for return home. At the request of surgeons, a new pharmaceutical support (NPS) has been developed to improve the ability of these patients to recall or find information that identify their prosthesis. Objectives : The main objective is to demonstrate that the new pharmaceutical support (NPS) increase the ability to memorize then find correct information of their prosthesis 6 months post-implantation Material and method : This study, approved by an ethic committee, takes place in the orthopedic and plastic surgery departments. The 236 adult patients included are hospitalized following the scheduled placement of either a breast or a hip or knee prosthesis. They are randomized, either in the NPS group or in the UPS comparator group. In both cases, patients benefit from the same written information: a patient-implant file and an information booklet specific to their prosthesis, validated by specialist surgeons, to prepare for their return home. The only difference between these 2 groups is that patients in the NPS group benefit from additional visual and oral information on the characteristics of their implant and on medical device vigilance during their hospitalization. In NPS group, pharmacist use specific photo and quiz. A telephone follow-up at the 6th month of the patients is carried out by a pharmacist to assess the patient's knowledge, using a standardized questionnaire. Expected results : Based on retrospective data already published, the main hypothesis is that the NPS is associated with an improvement in patient ability to remember the correct model or manufacturer of their prosthesis, compared to the UPS, 6 months after the operation.Secondary hypotheses are that NPS compared to UPS leads to an improvement in patients ability to preserve and find correct items related to theirs prosthesis at 6 months as well as an improvement in their knowledge of medical device vigilance and patient satisfaction declarations and a decrease in anxiety associated with prosthesis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
236

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

May 20, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

February 6, 2025

Status Verified

January 1, 2025

Enrollment Period

1.5 years

First QC Date

February 26, 2020

Last Update Submit

February 3, 2025

Conditions

Keywords

joint prosthesisbreast implantshealth education

Outcome Measures

Primary Outcomes (1)

  • pourcentage of patients able to recall the correct name of the manufacturer brand or model of their prosthesis after traceability checking by a questionnaire at 6 months postoperative.

    6 month

Secondary Outcomes (21)

  • pourcentage of patients who recall the reception of a patient-implant file during hospitalization by a questionnaire at 6 months postoperative.

    6 month

  • pourcentage of patients able to identify three correct information after traceability checking on the implantation, by a questionnaire at 6 months postoperative

    6 month

  • pourcentage of patients who recall health institution where the prosthesis was implanted by a questionnaire at 6 months postoperative

    6 month

  • pourcentage of patients who know there is a regular medical monitoring after implantation by a questionnaire at 6 months postoperative.

    6 month

  • pourcentage of patients who recall material (s) composing the prosthesis by a questionnaire at 6 months postoperative.

    6 month

  • +16 more secondary outcomes

Study Arms (2)

New pharmaceutical support (NPS)

EXPERIMENTAL

An NPS is an interview comprising the following elements: The delivery of the identification sheet of their implants with: * a quiz to focus the patient's attention * a description of the characteristics of their prosthesis using a specific photo of their implant * a presentation of the medical device vigilance. * an explanation of the value of the identification sheet for their implant, An in-depth presentation of an information booklet on living at home with their prosthesis and on medical and paramedical monitoring. For patients in orthopedic surgery: a booklet specific to their prosthesis and the surgical approach For plastic surgery patients, the information sheets published by the French Society of Plastic Reconstructive and Aesthetic Surgery (SOF.CPRE). A time to answer any questions the patient may have

Other: New pharmaceutical support (NPS)

Usual pharmaceutical support (UPS)

NO INTERVENTION

An UPS is an interview comprising the following elements: * The delivery of the same patient-implant sheet as in arm 1, but without additional oral information. * The delivery and oral presentation of the same booklet as practiced in the arm 1 (NPS). * And a time to answer any questions from the patient months

Interventions

The only difference between these 2 groups is that patients in the NPS group benefit from additional visual and oral information on the characteristics of their implant and on medical device vigilance during their hospitalization.

New pharmaceutical support (NPS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18 or over
  • Patient hospitalized following the scheduled placement of one of the following prostheses: three-compartment knee prostheses or total hip prosthesis or breast implant
  • French-speaking or non-French-speaking patient accompanied by a French-speaking support person
  • Patient having received complete information and having signed a free and informed consent for the research
  • Patient affiliated to a social security scheme (beneficiary or entitled)

You may not qualify if:

  • Patient having been operated on for the installation of an orthopedic prosthesis not programmed within the framework of a trauma emergency.
  • Patient suffering from post-operative confusional syndrome;
  • Non-French speaking patient unaccompanied or accompanied by a non-French speaking support person
  • Patient on state medical aid
  • Persons referred to in articles L1121-5, 6 and 8 of the public health code (corresponds to protected persons): pregnant woman, parturient, nursing mother, person deprived of liberty by judicial or administrative decision, person subject to legal protection measure, hospitalized for psychiatric disorder.
  • Patient who has already had postoperative pharmaceutical support for the placement of the same type of prosthesis on the contralateral limb
  • Patient suffering from a known cognitive or memory disorder.
  • Patient expressly refusing to participate in the telephone interview

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR

Créteil, 94010, France

Location

MeSH Terms

Conditions

Health Education

Condition Hierarchy (Ancestors)

Adherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study is a prospective, multicentric, controlled, single-blind, randomized trial in two parallel arms
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2020

First Posted

March 10, 2020

Study Start

May 20, 2020

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

February 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

data are own by Assistance Publique - Hôpitaux de Paris, please contact sponsor for further information

Locations